Abstracts tagged "assessment and rheumatoid arthritis (RA)"

Abstract Number: 369 • 2014 ACR/ARHP Annual Meeting
Validation of Snapshot, a Rheumatoid Arthritis Assessment Tool, Against CDAI, DAS28 (ESR), and DAS28 (CRP) in Canadian Patients with Rheumatoid Arthritis
William G Bensen¹, Wynn Bensen², Melissa Deamude², Cynthia Mech³, Robert Bensen⁴, Arthur N. Lau⁵ and Alpesh Shah⁶, ¹St Josephs Hospital and McMaster University, Hamilton, ON, Canada, ²Dr William G Bensen Medicine Professional Corp, Rheumatology Health Team, Dr. Bensen's Rheumatology Clinic, Hamilton, ON, Canada, ³Dr. William G. Bensen, Rheumatology Health Team, Dr. Bensen's Rheumatology Clinic, Hamilton, ON, Canada, ⁴Rheumatology Health Team, Dr. Bensen's Rheumatology Clinic, Hamilton, ON, Canada, ⁵Rheumatology and Clinical Epidemiology, Division of Rheumatology, McMaster University, Hamilton, ON, Canada, ⁶Epidemiology and Biostatistics, University of Western Ontario, MSc in Clinical Epidemiology, University of Western Ontario, London, ON, Canada
Background/Purpose: Measuring disease activity in Rheumatoid Arthritis (RA) remains an elusive goal. Both DAS and CDAI have an inherent weakness because similar numbers can result…
Abstract Number: 832 • 2013 ACR/ARHP Annual Meeting
Factors That Affect Tender and Swollen Joint Counts In Rheumatoid Arthritis
Christine L. Amity¹, Marisa Eckels², Kenneth N. Gold³, Kelly A. Reckley⁴, Niveditha Mohan⁵, Stephen R. Wisniewski⁶, Elizabeth A. Schlenk⁷, Marc C. Levesque^8,9 and Terence W. Starz¹⁰, ¹Rheumatology & Clinical Immun, Univ of Pittsburgh, Pittsburgh, PA, ²Arthritis and Internal Medicine Associates, University of Pittsburgh Medical Center, Pittsburgh, PA, ³Arthritis & Internal Medicine, Pittsburgh, PA, ⁴Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, ⁵Div of Rheum & Clin Immunol, Univ of Pittsburgh Arth Inst, Pittsburgh, PA, ⁶Epidemiology Data Center, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA, ⁷School of Nursing, University of Pittsburgh, Pittsburgh, PA, ⁸Division of Rheumatology and Clinical Immunology, University of Pittsburgh Department of Medicine, Pittsburgh, PA, ⁹Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, ¹⁰Arth & Internal Med Associates, Pittsburgh, PA
Background/Purpose: Quantitative joint counts are used to determine rheumatoid arthritis (RA) disease activity and are increasingly important for routine clinical practice to optimize patient care.…
Abstract Number: 79 • 2012 ACR/ARHP Annual Meeting
Physician’s Global Assessment Is Affected by Physician’s Age and Gender, but Not by Patient Age and Gender in Rheumatoid Arthritis Patients Treated in Routine Care. Data From the Danish Nationwide Danbio Registry
Cecilie Lindstrom Egholm¹, Theodore Pincus², Lene Dreyer³, Torkell Ellingsen⁴, Bente Glintborg³, Marcin Kowalski⁵, Tove Lorenzen⁴, Ole Rintek Madsen⁶, Henrik Nordin⁷, Claus Rasmussen⁸ and Merete L. Hetland⁹, ¹Copenhagen University Hospital / DANBIO at Glostrup, Copenhagen, Denmark, ²Rheumatology, Rush University Medical Center, Chicago, IL, ³Copenhagen University Hospital at Gentofte, Gentofte, Denmark, ⁴Diagnostic Centre, Region Hospital Silkeborg, Silkeborg, Denmark, ⁵Aalborg University Hospital, Aalborg, Denmark, ⁶Dept. of Rheumatoglogy/C, Copenhagen University Hospital Gentofte, Hellerup, Denmark, ⁷Rigshospitalet, Copenhagen, Denmark, ⁸Vendsyssel Teaching Hospital/Aalborg University, Hjoerring, Denmark, ⁹Copenhagen University Hospital Glostrup, Copenhagen, Denmark
Background/Purpose: Several studies have shown that significant discordance exists between patient (PATGL) and physician (DOCGL) global measures of rheumatoid arthritis (RA) disease activity. These studies…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].